Financials
- Market Capitalization 2.58 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.71
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1816 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 26.53 USD | +2.79% | +0.57% | +5.32% | -16.12% | 2.62 B USD | ||
| 1818 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 10.17 USD | +2.52% | +4.20% | +15.31% | +22.97% | 2.60 B USD | ||
| 1829 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 35.66 USD | +4.18% | +1.54% | +9.05% | +19.91% | 2.57 B USD | ||
| 1830 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 29.04 USD | +13.57% | +11.69% | +10.84% | -28.07% | 2.57 B USD |